Return to Article Details
CONTROL OF SECONDARY HYPERPARATIREOSIS BY INTRAVENOUS INTRODUCTION OF PARSABIV IN PATIENTS WITH CHRONIC KIDNEY DISEASE V D STAGE IN HEMODIALYSIS
Download
Download PDF